Alpine Immune Sciences (ALPN) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…
Best AI Trading & Performance Tools

December 21, 2024 Best AI Trading & Performance Tools

Ever find yourself overwhelmed by the rapid twists and turns of the stock market? I know the feeling—one moment you’re riding high, and…
Best Economic Calendars For Traders

December 21, 2024 Best Economic Calendars For Traders

You know that feeling when a crucial financial announcement catches you off guard, and suddenly your trading plans are turned upside down? We’ve…
When to Switch Payroll Solutions and How to Make a Smooth Transition

December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition

Payroll solutions are important for every business, as without them, you cannot make the right choices and calculations in your payment system. However,…

Alpine Immune Sciences (ALPN) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: January 20, 2025 (01:26)

Sector: Healthcare

The share price of Alpine Immune Sciences, Inc. (ALPN) now

This company is DELISTED
Latest session on the 9th of September for
Alpine Immune Sciences, Inc. is negative
Trading Volume: 2
Open: 64.97 /  High: 64.97 /  Low: 64.97
Current value: $64.97

Are you interested in Alpine Immune Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alpine Immune Sciences stock price in 2025, 2026, 2027. How much will one Alpine Immune Sciences share be worth in 2025 - 2027?

When should I take profit in Alpine Immune Sciences stock? When should I record a loss on Alpine Immune Sciences stock? What are analysts' forecasts for Alpine Immune Sciences stock? What is the future of Alpine Immune Sciences stock? We forecast Alpine Immune Sciences stock performance using neural networks based on historical data on Alpine Immune Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alpine Immune Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alpine Immune Sciences shares. This happens once a day.


Historical and forecast chart of Alpine Immune Sciences stock

The chart below shows the historical price of Alpine Immune Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alpine Immune Sciences stock price can be found in the table below.

No data

Long-term forecasts by years.

Alpine Immune Sciences, Inc. Is a biopharmaceutical company. The company is focused on the discovery and development of protein immunotherapy for the treatment of cancer, autoimmune and inflammatory diseases. The Company’s scientific platform uses a directed evolutionary process to convert native immune system proteins from the immunoglobulin superfamily (IgSF) into multipurpose therapeutic drugs capable of modulating the human immune system. Its candidate products include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulant (ICOS) and differentiation cluster 28 (CD28) antagonist for the treatment of autoimmune and inflammatory diseases. His cancer program is ALPN-202, a conditional CD28 co-stimulator and dual checkpoint inhibitor for cancer treatment. ALPN-303 is a dual antagonist of B-cell cytokines for the treatment of B-cell mediated diseases.

Trending Themes in the Healthcare Sector

Alpine Immune Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 21 66.34 64.97 67.70 4.20
Jan 22 65.86 64.28 66.79 3.90
Jan 23 64.05 63.61 64.51 1.42
Jan 24 64.41 63.97 65.44 2.30
Jan 25 64.86 64.18 66.30 3.30
Jan 26 65.19 64.25 66.05 2.80
Jan 27 65.05 64.45 66.05 2.48
Jan 28 65.89 65.47 67.41 2.96
Jan 29 65.12 64.10 65.82 2.68
Jan 30 66.02 65.56 66.61 1.60
Jan 31 64.65 63.47 65.39 3.03
Feb 01 65.39 64.23 66.43 3.42
Feb 02 66.25 65.63 67.05 2.15
Feb 03 66.67 65.73 67.55 2.77
Feb 04 68.63 67.41 69.74 3.45
Feb 05 68.09 66.50 69.69 4.79
Feb 06 69.52 68.38 70.82 3.57
Feb 07 69.17 67.99 70.08 3.08
Feb 08 68.75 67.91 69.58 2.46
Feb 09 68.65 67.81 69.14 1.97
Feb 10 68.86 68.32 69.54 1.78
Feb 11 69.56 68.01 70.44 3.56
Feb 12 69.66 68.87 71.19 3.37
Feb 13 70.29 69.49 71.07 2.28
Feb 14 72.36 71.16 73.62 3.45
Feb 15 74.51 72.78 76.20 4.70
Feb 16 74.35 73.28 76.07 3.80
Feb 17 74.35 73.26 75.51 3.08
Feb 18 74.77 73.72 75.54 2.46
Feb 19 75.58 74.08 76.35 3.06

Alpine Immune Sciences Daily Price Targets


Alpine Immune Sciences Stock Forecast 01-21-2025.

Forecast target price for 01-21-2025: $66.34.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 4.028%.
Pessimistic target level: 64.97
Optimistic target level: 67.70

Alpine Immune Sciences Stock Forecast 01-22-2025.

Forecast target price for 01-22-2025: $65.86.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.757%.
Pessimistic target level: 64.28
Optimistic target level: 66.79

Alpine Immune Sciences Stock Forecast 01-23-2025.

Forecast target price for 01-23-2025: $64.05.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 1.400%.
Pessimistic target level: 63.61
Optimistic target level: 64.51

Alpine Immune Sciences Stock Forecast 01-24-2025.

Forecast target price for 01-24-2025: $64.41.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 2.244%.
Pessimistic target level: 63.97
Optimistic target level: 65.44

Alpine Immune Sciences Stock Forecast 01-25-2025.

Forecast target price for 01-25-2025: $64.86.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.199%.
Pessimistic target level: 64.18
Optimistic target level: 66.30

Alpine Immune Sciences Stock Forecast 01-26-2025.

Forecast target price for 01-26-2025: $65.19.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 2.724%.
Pessimistic target level: 64.25
Optimistic target level: 66.05

ALPN (ALPN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Feb. 65.49 57.95 68.95 15.96
Mar. 73.45 66.17 78.86 16.10
Apr. 73.81 64.71 81.84 20.92
May. 63.53 61.40 69.63 11.82
Jun. 55.10 50.25 58.27 13.77
Jul. 63.65 56.62 70.47 19.65
Aug. 73.83 70.17 81.86 14.29
Sep. 75.96 67.93 79.72 14.79
Oct. 76.68 69.08 80.73 14.44
Nov. 79.51 69.58 87.65 20.61
Dec. 83.83 80.75 93.49 13.63

Alpine Immune Sciences forecast for this year


Alpine Immune Sciences Stock Prediction for Feb 2025

An uptrend is forecast for this month with an optimal target price of $65.4898. Pessimistic: $57.95. Optimistic: $68.95


Alpine Immune Sciences Stock Prediction for Mar 2025

An uptrend is forecast for this month with an optimal target price of $73.4533. Pessimistic: $66.17. Optimistic: $78.86


Alpine Immune Sciences Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $73.8059. Pessimistic: $64.71. Optimistic: $81.84


Alpine Immune Sciences Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $63.5321. Pessimistic: $61.40. Optimistic: $69.63


Alpine Immune Sciences Stock Prediction for Jun 2025

An downtrend is forecast for this month with an optimal target price of $55.095. Pessimistic: $50.25. Optimistic: $58.27


Alpine Immune Sciences Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $63.6458. Pessimistic: $56.62. Optimistic: $70.47


Alpine Immune Sciences Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $73.8291. Pessimistic: $70.17. Optimistic: $81.86


Alpine Immune Sciences Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $75.9554. Pessimistic: $67.93. Optimistic: $79.72


Alpine Immune Sciences Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $76.6846. Pessimistic: $69.08. Optimistic: $80.73


Alpine Immune Sciences Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $79.5066. Pessimistic: $69.58. Optimistic: $87.65


Alpine Immune Sciences Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $83.8317. Pessimistic: $80.75. Optimistic: $93.49



Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 88.39 79.34 92.21 13.96
Feb 85.85 81.18 93.40 13.09
Mar 84.34 74.22 92.16 19.47
Apr 97.02 92.36 106.33 13.14
May 104.94 95.03 111.32 14.63
Jun 114.51 103.33 118.17 12.56
Jul 118.17 113.44 132.92 14.65
Aug 135.76 125.11 144.44 13.38
Sep 117.73 108.31 126.39 14.31
Oct 107.93 97.92 119.16 17.83
Nov 110.35 100.29 122.36 18.04
Dec 103.46 96.18 107.60 10.62

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 118.69 106.92 132.56 19.34
Feb 115.28 105.13 125.79 16.42
Mar 113.98 108.88 118.73 8.30
Apr 109.43 104.87 120.81 13.19
May 106.45 102.02 117.52 13.19
Jun 95.89 84.54 102.18 17.27
Jul 87.45 81.43 90.67 10.19
Aug 90.81 83.83 93.71 10.54
Sep 94.30 87.81 103.50 15.16
Oct 89.62 81.73 92.77 11.90
Nov 94.64 88.58 104.93 15.58
Dec 93.88 84.87 104.85 19.05

Alpine Immune Sciences information and performance

Alpine Immune Sciences Address

N/A

Market Capitalization: N/A $

Market capitalization of the Alpine Immune Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALPN shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Alpine Immune Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.